Independent operating insight for investors evaluating plasma collection, fractionation, and the companies that serve them.
Donors, liters, and a price per liter make a clean model. The reality underneath is not: release rates, inspection findings, labor markets, ramp-up time to licensure, fractionator contract terms, and policy that differs by country and changes over time.
Generalist diligence teams rarely see those operating details, and they are where value is made or lost.
Cost per liter measured on liters released for manufacturing, not just collected.
Inspection history, findings, and how policy in each market could move.
The operating model, the people, and the plan behind the projections.
From a single question to full operating diligence.
Diligence on plasma assets and companies before you commit: true cost per liter, release rate, inspection and audit history, regulatory exposure, management depth, and the realism of the growth plan.
Where demand, supply, and policy are moving, by region.
An operator’s review of new collection ventures and national program bids.
CPL improvement, scaling, and integration after the deal.
Senior plasma operators at the board table or on call.
Operations prepared to hold their value under a buyer’s diligence.
Calls with vetted practitioners from our Expert Network.
How equipment, software, and service providers fit the industry’s needs.
A clear view of what supports the price and what puts it at risk.
Cost per liter, release rate, and ramp-up tested against reality.
Priorities for value creation once the deal closes.
